Risk: benefit ratio in the treatment of psoriasis with systemic retinoids.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 2142437.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This is a review of the efficacy of etretinate/acitretin in the treatment of psoriasis and of the currently reported side-effects. The data indicate that retinoids bring significant improvement (if not total clearing) with frequent low-morbidity but rarely serious side-effects. The most serious side-effect of etretinate/acitretin is teratogenicity.
Medical subject headings
- Etretinate
- Psoriasis
- Tretinoin